Matthias B. Moor

机构：University Hospital of Bern, Karolinska Institutet, University Clinic for Nephrology and Hypertension, Diabetology and Endocrinology, Hypertension Institute · ORCID：0000-0002-7717-651X

发表论文 63 篇 · 总被引 1070 次 · h-index 14

代表论文

• Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trial (2025 · Nature Medicine · 被引 25)
• HPV Vaccination in Immunosuppressed Patients with Established Skin Warts and Non-Melanoma Skin Cancer: A Single-Institutional Cohort Study (2023 · Vaccines · 被引 16)
• Defining the molecular response to ischemia-reperfusion injury and remote ischemic preconditioning in human kidney transplantation (2024 · PLoS ONE · 被引 4)
• Fgf23 expression increases atherosclerotic plaque burden in male ApoE deficient mice (2025 · Atherosclerosis · 被引 3)
• Apixaban dosing in hemodialysis - can drug level monitoring mitigate controversies? (2024 · BMC Nephrology · 被引 3)
• Sex differences in symptoms following the administration of BNT162b2 mRNA COVID-19 vaccine in children below 5 years of age in Germany (CoVacU5): a retrospective cohort study (2024 · Biology of Sex Differences · 被引 2)